America’s borders have allowed the ‘white plague’ of tuberculosis to surge back, threatening families with a deadlier, antibiotic-resistant foe.
Story Snapshot
- US TB cases hit 10,388 in 2024, up from prior years, fueled by post-COVID delays and high-risk immigrant communities.
- Multidrug-resistant TB (MDR-TB) rises, with no effective adult vaccine, positioning it as deadlier than declining COVID in case counts and persistence.
- Clusters in prisons, jails, and urban areas like NYC highlight failures in screening and border health vetting.
- Experts demand better diagnostics and social interventions, but federal inaction echoes past overspending on foreign wars over domestic health.
TB Resurgence Hits 10,388 Cases in 2024
United States tuberculosis cases reached 10,388 in 2024, an increase that marks TB as one of the deadliest infectious diseases. Post-COVID-19 disruptions from 2020 to 2023 caused missed diagnoses and treatment delays, especially in high-risk groups like immigrants and ethnic minorities.
These gaps allowed airborne transmission to thrive in congregate settings such as prisons and urban immigrant communities. Federal health agencies report concentrations in jails and cities, underscoring neglected public health priorities while resources pour into endless overseas conflicts.
'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant https://t.co/RbrjT2kbyJ pic.twitter.com/nD0UC5lwm8
— New York Post (@nypost) March 25, 2026
Post-Pandemic Neglect Fuels ‘White Plague’ Return
Tuberculosis, historically the ‘white plague’ from its pallor-inducing effects in 19th-century America, declined mid-20th century through antibiotics and sanitation. Today it persists as a disease of poverty, incarceration, and migration from high-burden nations. Immigration without health vetting exacerbates cases alongside HIV comorbidities.
Unlike COVID’s vaccine breakthroughs, TB lacks an effective adult vaccine; the outdated BCG fails modern needs. Conservatives see this as government overreach failing at borders, prioritizing globalism over American families’ safety.
MDR-TB Threatens Untreatable Epidemics
Multidrug-resistant TB (MDR-TB) emerges as a grave concern, bred by incomplete treatments and onerous 4-6 month regimens. Experts from University of Utah note transmission flourishes in neglect and pollution, urging genomic tracking in high-risk settings like prisons.
PAHO reports 350,000 cases across the Americas in 2024, with 77,000 undiagnosed, linking 29% of deaths to TB-HIV coinfections. Long-term, MDR spread risks epidemics straining elimination goals, with high treatment costs burdening taxpayers already hit by inflation and energy crises from Iran war disruptions.
New York City saw an 11% case drop in 2025, yet rates stay elevated nationally. A February 2026 review stresses latent TB infection screening gaps and social determinants like poverty. World TB Day on March 24, 2026, highlighted resistance and underdiagnosis.
NEWS🚨: 'White plague' is on the rise in the US – it's deadlier than Covid and becoming antibiotic resistant, says NYP pic.twitter.com/hHoZ4EHqZP
— All day Astronomy (@forallcurious) March 25, 2026
Expert Calls for Prevention Over Cure
Dr. Walter and Dr. Carey from University of Utah emphasize congregate screening and shorter regimens to combat resistance. PAHO urges community-based primary care for early detection, reducing transmission and sequelae. Optimism surrounds rapid molecular tests and interferon gamma assays, but pessimism lingers over vaccine constraints and adult inefficacy.
The 2026 resurgence review integrates clinical insights with social responses, warning post-COVID vulnerabilities in vulnerable populations demand immediate action to protect conservative values of family health and self-reliance.
Sources:
World Tuberculosis Day 2026: Primary health care is key to more accessible, people-centered
World Tuberculosis Day: What You Should Know 2026
2026 Tuberculosis Outbreaks: Ending with Innovative Vaccines? 2026-02-22
